CHF Solutions Retains CORE IR as its Investor Relations Firm of Record
May 24 2017 - 07:00AM
CHF Solutions, Inc. (NASDAQ:CHFS) announced today that it has
retained CORE IR as its Investor Relations firm of record. Core IR
will provide investor relations and shareholder communications
services and assist the company in expanding market awareness and
engagement with the institutional and retail investment
communities.
CORE IR represents itself as a boutique investor relations firm
that specializes in leveraging investment, growth, and exposure
strategies for small to mid-sized companies through an integrated
approach to relationship development and shareholder
communications.
"We are pleased to engage CORE IR, whose experience and
expertise will help to broaden CHF Solutions’ visibility and
engagement with the market,” said John Erb, Chief Executive Officer
and President of CHF Solutions. “We are keenly focused on
strengthening our relationships within the institutional and retail
segments, to convey the value thesis that CHF Solutions represents.
With Core IR, we will enhance our shareholder communications and
investor outreach and look forward to working with the CORE IR team
in expanding our IR efforts,” Mr. Erb concluded.
“The CORE IR team is thrilled to support CHF Solutions in
expanding their Investor Relations efforts with targeted investor
outreach and enhanced shareholder communications,” said Scott
Gordon, President of CORE IR. “The company’s fundamentals are
evolving with promise and together we will carry forward their
investment theses to the market in support of their Investor
Relations objectives,” he added.
About CHF SolutionsCHF
Solutions, Inc. (NASDAQ:CHFS) is an early-stage medical device
company focused on commercializing the Aquadex FlexFlow® System.
The company's commercial product, the Aquadex system, is indicated
for temporary (up to eight hours) ultrafiltration treatment of
patients with fluid overload who have failed diuretic therapy, and
extended (longer than 8 hours) ultrafiltration treatment of
patients with fluid overload who have failed diuretic therapy and
require hospitalization. Its objective is to improve the quality of
life for patients with heart failure and related
conditions. CHF Solutions is a Delaware corporation
headquartered in Minneapolis with wholly owned
subsidiaries in Australia and Ireland. The Company
has been listed on the NASDAQ Capital Market since February
2012.
Forward-Looking StatementsCertain statements in
this release are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995, including
statements that address the expected results of the company
retaining CORE IR, future operating performance, the promise of
evolving fundamental, and events or developments that we expect or
anticipate will occur in the future. Forward-looking statements are
predictions, projections and other statements about future events
that are based on current expectations and assumptions and, as a
result, are subject to risks and uncertainties. Many factors could
cause actual future events to differ materially from the
forward-looking statements in this release, including, without
limitation, those risk associated with our ability to execute on
our recently announced strategic realignment, the possibility that
we may be unable to raise sufficient funds necessary for our
anticipated operations, our post-market clinical data collection
activities, benefits of our products to patients, our expectations
with respect to product development and commercialization efforts,
our ability to increase market and physician acceptance of our
products, potentially competitive product offerings, intellectual
property protection, our ability to integrate acquired businesses,
our expectations regarding anticipated synergies with and benefits
from acquired businesses, and other risks and uncertainties
described in our filings with the SEC. Forward-looking statements
speak only as of the date when made. CHF Solutions does not assume
any obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise.
For further information, please contact:
Claudia Napal Drayton
Chief Financial Officer
CHF Solutions, Inc.
T: +1-952-345-4205
Investor Relations:
Bret Shapiro
Managing Partner
CORE IR
516 222 2560
brets@coreir.com
www.coreir.com
CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart
From Feb 2024 to Mar 2024
CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart
From Mar 2023 to Mar 2024